Study on Oral TGF-beta Receptor I Inhibitor Vactosertib with Standard Chemoradiotherapy for Esophageal Cancer | Clinical Trial

Study on Oral TGF-beta Receptor I Inhibitor Vactosertib with Standard Chemoradiotherapy for Esophageal Cancer | Clinical Trial | Right2Hope